Primary Category:
Treatment Protocols
Disease Category:
Bladder, Genitourinary
Status:
Open
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
NCT#04164082
07/19/17, no new patients may register (Step 1) to the NF2 Grade I or Grade II/III cohorts.
Effective 09/30/20, new patient registration (Step 1) of A031803 is reopened to accrual.
